PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Crude methanolic extracts of leaves, fruits, seeds, stem, and root barks exhibit broad-spectrum antibacterial activity [PMID:12048021]. Dichloromethane crude leaf extract showed activity against Salmonella typhi, Escherichia coli, and Staphylococcus aureus [PMID:30891316]. Specific triterpenes showed activity against Staphylococcus aureus and Pseudomonas aeruginosa [PMID:21628919].
Triterpenes from leaves exhibited antifungal activity against Candida albicans [PMID:21628919]. Other extracts showed antifungal activity to a lesser extent [PMID:8786654].
Evidence summary
PubMed sources
- 1.PMID: 21628919 (2011) — New triterpenes from Barringtonia asiatica. · Chemical & pharmaceutical bulletin
- 2.PMID: 21929282 (2012) — A new triterpene from Barringtonia asiatica. · Natural product research
- 3.PMID: 12048021 (2002) — Antibacterial, antifungal activities of Barringtonia asiatica. · Fitoterapia
- 4.PMID: 39895860 (2025) — The complete chloroplast genome of Barringtonia asiatica (L.) Kurz (Lecythidaceae). · Mitochondrial DNA. Part B, Resources
- 5.PMID: 38157253 (2024) — The evolution history of an allotetraploid mangrove tree analysed with a new tool Allo4D. · Plant biotechnology journal